Form 4: Guardant Health Director Myrtle S. Potter Reports Stock Transactions

Director Myrtle S. Potter of Guardant Health, Inc. reports the vesting of restricted stock units and subsequent disposal of shares.

Summary

• Myrtle S. Potter, a director at Guardant Health, Inc., filed a Form 4 with the SEC.
• The filing reports the vesting of 69 restricted stock units on December 15, 2024.
• These units converted into 69 shares of common stock.
• Following the transaction, Ms. Potter directly owns 13,722 shares of common stock.
• The restricted stock units were part of an award that began vesting on October 15, 2022, with the remaining units vesting monthly over three years.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing a standard stock transaction, and does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It provides transparency into the stock ownership of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The vesting schedule of the restricted stock units is typical for employee and director compensation packages.
• The transaction is similar to those seen at other companies with equity-based compensation plans, such as Illumina or Exact Sciences.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects a change in insider ownership.

Key Dates

Keywords

Form 4, Guardant Health, Myrtle S. Potter, Restricted Stock Units, Stock Transaction, Director, SEC Filing